Sign in

CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
460571712
Phone
484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Shares withheld for taxes Chief Medical Officer gave up 9,330 shares (to pay taxes)
  4. 8-K Event Regulation FD disclosure · Other events
  5. 4 Open-market sale 10% owner sold 300,000 shares at $4.53 ($1,359,000)
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. ARS Other Annual Report to Security Holders
  8. DEFA14A Proxy Proxy Materials
  9. DEF 14A Proxy Proxy Statement
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 8-K Event Regulation FD disclosure
  14. 8-K Event Regulation FD disclosure
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 677 shares (to pay taxes)
  16. 10-K Report Annual Report
  17. 8-K Event Results of operations
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 44 · 872 filings